Skip to main content
Clinical Trials/ChiCTR-ORC-16009358
ChiCTR-ORC-16009358
Completed
回顾性研究

氨甲环酸的不同用法在初次单侧全膝关节表面置换术中的作用

国家卫生和计划生育委员会1 site in 1 country560 target enrollmentStarted: June 26, 2013Last updated:

Overview

Phase
回顾性研究
Status
Completed
Sponsor
国家卫生和计划生育委员会
Enrollment
560
Locations
1
Primary Endpoint
Haemoglobin loss

Overview

Brief Summary

目前,暂未有一项研究同时评估氨甲环酸哪种给药途径在降低术后失血量、输血量、额外费用和副作用比如(血栓栓塞的并发症等)方面是最好的。因此,该研究的目的是针对要进行初次单侧全膝表面置换术的患者,同时评估静脉给药、关节局部用药和口服给药中哪种途径对患者最有利。

Study Design

Study Type
观察性研究
Primary Purpose
队列研究

Eligibility Criteria

Ages
47 to 84 (—)
Sex
All

Inclusion Criteria

  • 膝关节骨关节炎或类风湿性关节炎的患者;初次进行单侧膝关节表面置换术的患者;至少达到 3 周的随访时间;凝血机制正常;内科疾病(比如糖尿病、高血压等)在术前得到有效控制。

Exclusion Criteria

  • 要求一次进行双侧膝关节表面置换术的患者;膝关节翻修的患者;患有严重的肝肾、心血管和肺部疾病的患者;凝血性和出血性疾病;以及近期接受抗凝治疗的患者。

Arms & Interventions

intravenous group

The intravenous group received 20mg/kg of TXA administered intravenously 30 minutes before incising skin and the same dose and administration 12 hours postoperatively.

topical group

The topical group received 3.0g TXA (total 60ml solution) administered intra-articularly after subcutaneous tissue was sutured.

oral group

The oral group received 20mg/kg of TXA administered orally 2 hours preoperatively and the same dose and administration 12 hours postoperatively.

blank group

No TXA was used for the blank group.

Outcomes

Primary Outcomes

Haemoglobin loss

Time Frame: 48 hours postoperatively

Drainage volume

Time Frame: 48 hours postoperatively

Transfusion units

Additional cost

Secondary Outcomes

  • Tourniquet time
  • Thromboembolic complications
  • Wound healing

Investigators

Sponsor
国家卫生和计划生育委员会

Study Sites (1)

Loading locations...

Similar Trials